Trial Profile
A Randomized, Open-Label, Single-Center, Single-Dose, Two-Way Crossover Study in Healthy Subjects to Determine the Fed Bioequivalence of Oxycodone Tamper Resistant (OTR) 80-mg Tablets to OxyContin 80-mg Tablets.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2011
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Cancer pain; Pain
- Focus Pharmacokinetics
- Sponsors Purdue Pharma
- 12 Apr 2010 New trial record